OMO-1 is a compound that acts as an inhibitor of c-Met kinase, a receptor tyrosine kinase involved in cell signaling pathways related to tumor growth. It is primarily used as a research compound in studies investigating c-Met-mediated cellular processes.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing OMO-1?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Peficitinib
pharmaceutical raw material
Afatinib, (R)-
pharmaceutical raw material
Saxagliptin hydrate
pharmaceutical raw material
Isavuconazonium sulfate
pharmaceutical raw material
6-[difluoro-(6-pyridin-4-yl-[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methyl]quinoline
KOAWAWHSMVKCON-UHFFFAOYSA-N
C1=CC2=C(C=CC(=C2)C(C3=NN=C4N3N=C(C=C4)C5=CC=NC=C5)(F)F)N=C1
Sourcing OMO-1?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.